Shri P R Proteins Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
- Paid Up Capital ₹ 5.00 M
- Company Age 3 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 19.50 Cr
About Shri P R Proteins
Shri P R Proteins Private Limited (SPRPPL) is a Private Limited Indian Non-Government Company incorporated in India on 02 March 2021 (Three years and 11 months 13 days old ). Its registered office is in Jaipur, Rajasthan, India.
The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.00 M.
The company currently has active open charges totaling ₹19.50 Cr.
Dilip Jain, Ankit Agarwal, and Rajendra Jain serve as directors at the Company.
Company Details
-
Location
Jaipur, Rajasthan, India
-
Telephone
+91-XXXXXXXXXX
- Email Address
-
Website
-
-
Social Media
-
Corporate Identity Details
-
CIN/LLPIN
U15490RJ2021PTC073760
-
Company No.
073760
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
02 Mar 2021
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Jaipur
Industry
Who are the key members and board of directors at Shri P R Proteins?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Dilip Jain
|
Director | 02-Mar-2021 | Current |
|
Ankit Agarwal
|
Director | 02-Mar-2021 | Current |
|
Rajendra Jain
|
Director | 29-Mar-2023 | Current |
Financial Performance of Shri P R Proteins.
Shri P R Proteins Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shri P R Proteins?
In 2023, Shri P R Proteins had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Shri Amit Solvex Private LimitedDilip Jain and Ankit Agarwal are mutual person
Charges (Loans)
₹19.50 Cr
₹0
Charges Breakdown by Lending Institutions
- Others : 19.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 01 Sep 2022 | Others | ₹3.00 Cr | Open |
| 01 Sep 2022 | Others | ₹10.00 Cr | Open |
| 01 Sep 2022 | Others | ₹6.50 Cr | Open |
How Many Employees Work at Shri P R Proteins?
Unlock and access historical data on people associated with Shri P R Proteins, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shri P R Proteins, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shri P R Proteins's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.